The majority of CD4+ T-cell depletion during acute simian-human immunodeficiency virus SHIV89.6P infection occurs in uninfected cells

Journal of Virology

Volumn 88, Issue 6, 2014, Pages 3202-3212

  Matrajt, Laura ^a,b   Younan, Patrick M ^b   Kiem, Hans Peter ^a,b   Schiffer, Joshua T ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL DEATH; CONTROLLED STUDY; HOST RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; INFECTION SENSITIVITY; MACACA; MATHEMATICAL MODEL; PRIORITY JOURNAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; T CELL DEPLETION; VIRAL CLEARANCE; VIREMIA; VIRUS ENTRY; VIRUS LOAD; VIRUS STRAIN;

ANIMALS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; HIV; HIV INFECTIONS; HUMANS; LYMPHOCYTE DEPLETION; MACACA NEMESTRINA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84894589217     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03428-13     Document Type: Article

References (63)

1. + T-cell depletion in HIV infection: are we closer to understanding the cause? Nat. Med. 8:319-323. http://dx.doi.org/10.1038/nm0402-319.
2. + T cells go out of stock. Nat. Immunol. 1:285-289. http://dx.doi.org/10.1038/79724.
3. + T cell demographics and dynamics in lymphatic tissues. Annu. Rev. Immunol. 17:625-656.
4. + T-cell depletion in HIV disease. Nature 410:974-979. http://dx.doi.org/10.1038/35073648.
5. Sainski AM, Natesampillai S, Cummins NW, Bren GD, Taylor J, Saenz DT, Poeschla EM, Badley AD. 2011. The HIV-1-specific protein Casp8p41 induces death of infected cells through Bax/Bak. J. Virol. 85: 7965-7975. http://dx.doi.org/10.1128/JVI.02515-10.
6. Cooper A, Garcia M, Petrovas C, Yamamoto T, Koup RA, Nabel GJ. 2013. HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. Nature 498:376-379. http://dx.doi.org/10.1038/nature12274.
7. Badley AD, Pilon AA, Landay A, Lynch DH. 2000. Mechanisms of HIV-associated lymphocyte apoptosis. Blood 96:2951-2964. http://bloodjournal.hematologylibrary.org/content/96/9/2951.long.
8. + T cells in the gut: mechanism and therapeutic implications. Trends Pharmacol. Sci. 27:4-7. http://dx.doi.org/10.1016/j.tips.2005.11.005.
9. Cummins NW, Badley AD. 2010. Mechanisms of HIV-associated lymphocyte apoptosis: 2010. Cell Death Dis. 1:e99. http://dx.doi.org/10.1038/cddis.2010.77.
10. Gougeon ML. 2003. Apoptosis as an HIV strategy to escape immune attack. Nat. Rev. Immunol. 3:392-404. http://dx.doi.org/10.1038/nri1087.
11. Gougeon ML, Piacentini M. 2009. New insights on the role of apoptosis and autophagy in HIV pathogenesis. Apoptosis 14:501-508. http://dx.doi.org/10.1007/s10495-009-0314-1.
12. Ipp H, Zemlin A. 2013. The paradox of the immune response in HIV infection: when inflammation becomes harmful. Clin. Chim. Acta 416: 96-99. http://dx.doi.org/10.1016/j.cca.2012.11.025.
13. + T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200:761-770. http://dx.doi.org/10.1084/jem.20041196.
14. Fluur C, De Milito A, Fry TJ, Vivar N, Eidsmo L, Atlas A, Federici C, Matarrese P, Logozzi M, Rajnavolgyi E, Mackall CL, Fais S, Chiodi F, Rethi B. 2007. Potential role for IL-7 in Fas-mediated T cell apoptosis during HIV infection. J. Immunol. 178:5340-5350. http://www.jimmunol.org/content/178/8/5340.long.
15. Joshi A, Nyakeriga AM, Ravi R, Garg H. 2011. HIV Env glycoproteinmediated bystander apoptosis depends on expression of the CCR5 coreceptor at the cell surface and Env fusogenic activity. J. Biol. Chem. 286: 36404-36413. http://dx.doi.org/10.1074/jbc.M111.281659.
16. Wan ZT, Chen XL. 2010. Mechanisms of HIV envelope-induced T lymphocyte apoptosis. Virol. Sin. 25:307-315. http://dx.doi.org/10.1007/s12250-010-3148-7.
17. Doitsh G, Cavrois M, Lassen KG, Zepeda O, Yang Z, Santiago ML, Hebbeler AM, Greene WC. 2010. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 143: 789-801. http://dx.doi.org/10.1016/j.cell.2010.11.001.
18. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch-Crovo P, Siliciano RF. 1997. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183-188.
19. + T-cell depletion in simian HIV infection. J. Acquir. Immune Defic. Syndr. 41: 259-265. http://dx.doi.org/10.1097/01.qai.0000199232.31340.d3.
20. McCune JM, Hanley MB, Cesar D, Halvorsen R, Hoh R, Schmidt D, Wieder E, Deeks S, Siler S, Neese R, Hellerstein M. 2000. Factors influencing T-cell turnover in HIV-1-seropositive patients. J. Clin. Invest. 105:R1-R8. http://dx.doi.org/10.1172/JCI8647.
21. Mohri H, Perelson AS, Tung K, Ribeiro RM, Ramratnam B, Markowitz M, Kost R, Hurley A, Weinberger L, Cesar D, Hellerstein MK, Ho DD. 2001. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J. Exp. Med. 194:1277-1287. http://dx.doi.org/10.1084/jem.194.9.1277.
22. + T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J. Exp. Med. 187:1295-1303.
23. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RP, Miedema F. 1992. Programmed death of T cells in HIV-1 infection. Science 257:217-219.
24. Kiem HP, Wu RA, Sun G, von Laer D, Rossi JJ, Trobridge GD. 2010. Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo. Gene Ther. 17:37-4910. http://dx.doi.org/10.1038/gt.2009.118.
25. Trobridge GD, Beard BC, Gooch C, Wohlfahrt M, Olsen P, Fletcher J, Malik P, Kiem HP. 2008. Efficient transduction of pigtailed macaque hematopoietic repopulating cells with HIV-based lentiviral vectors. Blood 111:5537-5543. http://dx.doi.org/10.1182/blood-2007-09-115022.
26. Trobridge GD, Wu RA, Beard BC, Chiu SY, Munoz NM, von Laer D, Rossi JJ, Kiem HP. 2009. Protection of stem cell-derived lymphocytes in a primate AIDS gene therapy model after in vivo selection. PLoS One 4(11):e7693. http://dx.doi.org/10.1371/journal.pone.0007693.
27. + T cells and maintenance of virus specific immunity in a primate AIDS model. Blood 122:179-187. http://dx.doi.org/10.1182/blood-2013-01-482224.
28. Egelhofer M, Brandenburg G, Martinius H, Schult-Dietrich P, Melikyan G, Kunert R, Baum C, Choi I, Alexandrov A, von Laer D. 2004. Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides. J. Virol. 78:568-575. http://dx.doi.org/10.1128/JVI.78.2.568-575.2004.
29. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
30. Krakauer DC, Nowak M. 1999. T-cell induced pathogenesis in HIV: bystander effects and latent infection. Proc. Biol. Sci. 266:1069-1075.
31. Perelson AS, Nelson PW. 1998. Mathematical analysis of HIV-1 dynamics in vivo. SIAM Rev. 41:3-44. http://dx.doi.org/10.2478/v100006-010-0045-z.
32. Nowak MA, Lloyd AL, Vasquez GM, Wiltrout TA, Wahl LM, Bischofberger N, Williams J, Kinter A, Fauci AS, Hirsch VM, Lifson JD. 1997. Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J. Virol. 71:7518-7525.
33. Burnham KP, Anderson DR. 2002. Model selection and multimodel inference: a practical information-theoretic approach, 2nd ed. Springer, New York, NY.
34. Chen HY, Di Mascio M, Perelson AS, Ho DD, Zhang L. 2007. Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques. Proc. Natl. Acad. Sci. U.S.A. 104:19079-19084. http://dx.doi.org/10.1073/pnas.0707449104.
35. Bonhoeffer S, Coffin JM, Nowak MA. 1997. Human immunodeficiency virus drug therapy and virus load. J. Virol. 71:3275-3278.
36. Burg D, Rong L, Neumann AU, Dahari H. 2009. Mathematical modeling of viral kinetics under immune control during primary HIV-1 infection. J. Theor. Biol. 259:751-759. http://dx.doi.org/10.1016/j.jtbi.2009.04.010.
37. Markowitz M, Louie M, Hurley A, Sun E, Di Mascio M, Perelson AS, Ho DD. 2003. A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. J. Virol. 77:5037-5038. http://dx.doi.org/10.1128/JVI.77.8.5037-5038.2003.
38. Stafford MA, Corey L, Cao Y, Daar ES, Ho DD, Perelson AS. 2000. Modeling plasma virus concentration during primary HIV infection. J. Theor. Biol. 203:285-301. http://dx.doi.org/10.1006/jtbi.2000.1076.
39. Bonhoeffer S, Funk GA, Gunthard HF, Fischer M, Muller V. 2003. Glancing behind virus load variation in HIV-1 infection. Trends Microbiol. 11:499-504. http://dx.doi.org/10.1016/j.tim.2003.09.002.
40. Ribeiro RM, Qin L, Chavez LL, Li D, Self SG, Perelson AS. 2010. Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection. J. Virol. 84:6096-6102. http://dx.doi.org/10.1128/JVI.00127-10.
41. + T cell counts but have minimal effects on viral load. PLoS Comput. Biol. 6(11):e1001012. http://dx.doi.org/10.1371/journal.pcbi.1001012.
42. + T cells in multiple tissues during acute SIV infection. Nature 434:1093-1097. http://dx.doi.org/10.1038/nature03501.
43. + T cells and the control of human immunodeficiency virus infection. J. Virol. 78:10096-10103. http://dx.doi.org/10.1128/JVI.78.18.10096-10103.2004.
44. Kaur A, Hale CL, Ramanujan S, Jain RK, Johnson RP. 2000. Differential dynamics of CD4(+) and CD8(+) T-lymphocyte proliferation and activation in acute simian immunodeficiency virus infection. J. Virol. 74: 8413-8424. http://dx.doi.org/10.1128/JVI.74.18.8413-8424.2000.
45. Xu H, Wang X, Lackner AA, Veazey RS. 2013. CD8 down-regulation and functional impairment of SIV-specific cytotoxic T lymphocytes in lymphoid and mucosal tissues during SIV infection. J. Leukoc. Biol. 93: 943-950. http://dx.doi.org/10.1189/jlb.1112580.
46. + T cells. Math. Biosci. 114:81-125.
47. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586.
48. Ramratnam B, Bonhoeffer S, Binley J, Hurley A, Zhang L, Mittler JE, Markowitz M, Moore JP, Perelson AS, Ho DD. 1999. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet 354:1782-1785.
49. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122.
50. Finkel TH, Tudor-Williams G, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM, Kupfer A. 1995. Apoptosis occurs predom-inantly in bystander cells and not in productively infected cells of HIVand SIV-infected lymph nodes. Nat. Med. 1:129-134.
51. Ameisen JC, Capron A. 1991. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol. Today 12:102-105.
52. + T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J. Gen. Virol. 84:1649-1661. http://dx.doi.org/10.1099/vir.0.19110-0.
53. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase AT. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362: 359-362.
54. Esser MT, Bess JWJ, Suryanarayana K, Chertova E, Marti D, Carrington M, Arthur LO, Lifson JD. 2001. Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1. J. Virol. 75:1152-1164. http://dx.doi.org/10.1128/JVI.75.3.1152-1164.2001.
55. Garg H, Mohl J, Joshi A. 2012. HIV-1 induced bystander apoptosis. Viruses 4:3020-3043. http://dx.doi.org/10.3390/v4113020.
56. Holm GH, Zhang C, Gorry PR, Peden K, Schols D, De Clercq E, Gabuzda D. 2004. Apoptosis of bystander T cells induced by human immunodeficiency virus type 1 with increased envelope/receptor affinity and coreceptor binding site exposure. J. Virol. 78:4541-4551. http://dx.doi.org/10.1128/JVI.78.9.4541-4551.2004.
57. + T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions. J. Virol. 79:6299-6311. http://dx.doi.org/10.1128/JVI.79.10.6299-6311.2005.
58. Jekle A, Keppler OT, De Clercq E, Schols D, Weinstein M, Goldsmith MA. 2003. In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells. J. Virol. 77:5846-5854. http://dx.doi.org/10.1128/JVI.77.10.5846-5854.2003.
59. Silvestri G, Sodora DL, Koup RA, Paiardini M, O'Neil SP, McClure HM, Staprans SI, Feinberg MB. 2003. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18:441-452. http://dx.doi.org/10.1016/S1074-7613(03)00060-8.
60. + T-lymphocyte loss and dysfunction during primary simian immunodeficiency virus infection. J. Virol. 81:8009-8015. http://dx.doi.org/10.1128/JVI.00482-07.
61. Petravic J, Davenport MP. 2011. Simian-human immunodeficiency infection: is the course set in the acute phase? PLoS One 6(2):e17180. http://dx.doi.org/10.1371/journal.pone.0017180.
62. Roger PM, Breittmayer JP, Durant J, Sanderson F, Ceppi C, Brignone C, Cua E, Clevenbergh P, Fuzibet JG, Pesce A, Bernard A, Dellamonica P. 2002. Early CD4(+) T cell recovery in human immunodeficiency virusinfected patients receiving effective therapy is related to a down-regulation of apoptosis and not to proliferation. J. Infect. Dis. 185:463-470. http://dx.doi.org/10.1086/338573.
63. Kalams SA, Walker BD. 1998. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J. Exp. Med. 188: 2199-2204.